Chimerix (CMRX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CMRX Chimerix

Watchlist

0.992
-0.048-4.58%

Close Nov 12 16:00 ET

0.967
-0.026-2.58%

Post 17:25 ET

89.25MMarket Cap-1055P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Chimerix Price Target Maintained With a $11.00/Share by HC Wainwright & Co.
Dow JonesNov 11 11:22 ET · Ratings
Chimerix Analyst Ratings
BenzingaNov 11 11:10 ET · Ratings
Chimerix's Dordaviprone Shows Promising Efficacy in H3 K27M-mutant Diffuse Glioma With $11 Price Target
TipRanksNov 11 09:25 ET
Press Release: Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
Dow JonesNov 11 07:00 ET
Chimerix, Inc. (CMRX) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 7 21:40 ET · Conference Call
Chimerix, Inc. (CMRX) Q3 2024 Earnings Call Transcript
Earnings Call TranscriptsNov 7 21:34 ET

Comments

Jaguar8

Nov 11 06:01

NEWS

$Chimerix (CMRX.US)$
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
Chimerix (NASDAQ: CMRX) announced updated Phase 2 response assessment results for dordaviprone in treating recurrent H3 K27M-mutant diffuse midline glioma. Using the new RANO 2.0 criteria, the treatment showed a 28.0% overall response rate, with a median time to response of 4.6 months and a median duration of response of 10.4 months. The company plans...

101674396

Oct 28 11:57

$Chimerix (CMRX.US)$ …why high peak?

Goldman Sachs

Aug 20 15:05

Tonix initiates Phase II trial for emergency cocaine intoxication treatment
$Tonix Pharmaceuticals (TNXP.US)$

101674396

Aug 20 03:47

$Chimerix (CMRX.US)$ .. supposed be rise…but drop !!!!

Analysts Notebook

Aug 19 08:18

Columns Monkeypox Outbreak Drove Surge in These Company Shares

As health authorities worldwide work to contain the monkeypox outbreak, investors quickly buy shares in companies that might profit from efforts to control the disease.
Investors are buying up shares of vaccine producers, antiviral drug makers, and protective equipment companies, hoping to profit as they did during the coronavirus pandemic.
Bavarian Nordic, the only producer approved of the pox vaccine, saw its shares jump 16.5% on the day in...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Concept

Mpox (monkeypox)

Intraday-0.96%

CMRX Chimerix

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target